Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations.

Abstract

The efficacy of repeated entacapone dosing as an adjuvant to levodopa/DDC inhibitor treatment for Parkinson's disease with levodopa related fluctuations is verified.